Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.43 |
| ▸ | IGF1R | P08069 | 2/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.37 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.34 |
| ▸ | RAF1 | P04049 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.33 |
| ▸ | PIKFYVE | Q9Y2I7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7659035 | 1.00 | ADORA1 (0.52) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7659023 | 1.00 | ADORA1 (0.52) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7660818 | 0.90 | ADORA1 (0.49) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7660830 | 0.90 | ADORA1 (0.49) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7660825 | 0.90 | ADORA1 (0.49) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL9034835 | 0.87 | ADORA1 (0.55) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7666542 | 0.87 | ADORA1 (0.55) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7666546 | 0.87 | ADORA1 (0.55) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL6890986 | 0.87 | ADORA1 (0.51) | ADORA1MAPK1IGF1RAKT1MAPK14 | |
| SCHEMBL7660866 | 0.87 | ADORA1 (0.51) | ADORA1MAPK1IGF1RAKT1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3572617-B2 | — | — | 2004-10-06 | — | — | JP | claimed |
| JP-H09507485-A | — | — | 1997-07-29 | — | — | JP | claimed |
| EP-0737193-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-16 | — | — | EP | claimed |
| WO-1995018128-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-06 | — | — | WO | claimed |
| EP-0823254-B1 | NOVEL USE OF PYRAZOLOPYRIDINE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-07-17 | — | — | EP | disclosed |
| US-6355640-B1 | TREATMENT OF HYPERTENSION, UROGENITAL DISORDERS AND FORMED BY WITTIG REACTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| US-6232324-B1 | AS HYPERTENSIVE AGENTS FOR DIALYSIS INDUCED HYPOTENSION; ADMINISTERING COMPOUNDS SUCH AS 1-(3-(2-PHENYLPYRAZOLO(1,5-A) PYRIDIN-3-YL)ACRYLOYL)-2-(CARBOXY METHYL)PIPERIDINE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |
| EP-0823254-A1 | NOVEL USE OF PYRAZOLOPYRIDINE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0737193-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018128-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-06 | — | — | WO | disclosed |